United States · FDA National Drug Code directory

PANTOPRAZOLE SODIUM

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
62756-129_ef1bb9ed-b534-4698-abf5-836dcce85f45
Product NDC
62756-129
Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Composition / generic term
PANTOPRAZOLE SODIUM
Labeler
Sun Pharmaceutical Industries, Inc.
Marketing category
ANDA
Marketing start / end (source format)
20190901
Source listing expiry
20261231

Source-listed ingredients

  • PANTOPRAZOLE SODIUM — 40 mg/10mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 VIAL in 1 CARTON (62756-129-40) / 10 mL in 1 VIAL · 62756-129-40
  • 10 VIAL in 1 CARTON (62756-129-44) / 10 mL in 1 VIAL · 62756-129-44
  • 25 CARTON in 1 PACKAGE (62756-129-45) / 1 VIAL in 1 CARTON / 10 mL in 1 VIAL · 62756-129-45

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
PANTOPRAZOLE SODIUM — United States | Molindra Medicines